Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,401 to 1,420 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories. | Annu Rev Pathol | 2021 | 32289233 | PubTator, text mining | PubMed |
| Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. | Haematologica | 2021 | 32273478 | PubTator, text mining | PubMed |
| SPOP negatively regulates Toll-like receptor-induced inflammation by disrupting MyD88 self-association. | Cell Mol Immunol | 2021 | 32235916 | PubTator, text mining | PubMed |
| IRAK inhibitor can improve insulin sensitivity in insulin-resistant mice fed with a high-fat diet. | Asian Biomed (Res Rev News) | 2020 | 37551306 | PubTator, text mining | PubMed |
| Benefits and applications of microwave-assisted synthesis of nitrogen containing heterocycles in medicinal chemistry. | RSC Adv | 2020 | 35498463 | PubTator, text mining | PubMed |
| Comprehensively analyze the expression and prognostic role for ten-eleven translocations (TETs) in acute myeloid leukemia. | Transl Cancer Res | 2020 | 35117329 | PubTator, text mining | PubMed |
| Targeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyond. | Ann Lymphoma | 2020 | 34667996 | PubTator, text mining | PubMed |
| Ischemic postconditioning for stroke treatment: current experimental advances and future directions. | Cond Med | 2020 | 34396060 | PubTator, text mining | PubMed |
| TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection. | Front Immunol | 2020 | 33679711 | PubTator, text mining | PubMed |
| Dysregulated Monocyte and Neutrophil Functional Phenotype in Infants With Neonatal Encephalopathy Requiring Therapeutic Hypothermia. | Front Pediatr | 2020 | 33659224 | PubTator, text mining | PubMed |
| The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA. | Front Immunol | 2020 | 33643304 | PubTator, text mining | PubMed |
| Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease. | Front Immunol | 2020 | 33613511 | PubTator, text mining | PubMed |
| Integrated Analysis of circRNA-miRNA-mRNA Regulatory Networks in the Intestine of Sebastes schlegelii Following Edwardsiella tarda Challenge. | Front Immunol | 2020 | 33552082 | PubTator, text mining | PubMed |
| R848 Is Involved in the Antibacterial Immune Response of Golden Pompano (Trachinotus ovatus) Through TLR7/8-MyD88-NF-κB-Signaling Pathway. | Front Immunol | 2020 | 33537035 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming. | Front Cell Dev Biol | 2020 | 33505964 | PubTator, text mining | PubMed |
| Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. | Front Immunol | 2020 | 33505393 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Regulators of Immune Response Networks in Asthma and Chronic Obstructive Pulmonary Disease. | Front Immunol | 2020 | 33488613 | PubTator, text mining | PubMed |
| Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs. | J Immunol Res | 2020 | 33426096 | PubTator, text mining | PubMed |
| Modeling MyD88 Deficiency In Vitro Provides New Insights in Its Function. | Front Immunol | 2020 | 33424861 | PubTator, text mining | PubMed |
| Synthetic strategies for pyrrolo[2,1-f][1,2,4]triazine: the parent moiety of antiviral drug remdesivir. | Chem Heterocycl Compd (N Y) | 2020 | 33424029 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=71